AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch

AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch
AFT's Chinese licensee Hainan Haiyao is doing the groundwork for its China launch. (Image: AFT)
Rebecca Stevenson
AFT Pharmaceuticals' Chinese licensee is ramping up efforts to promote its first aid cream Crystaderm to Chinese consumers. Chinese firm Hainan Haiyao Co will get its first shipment of Crystaderm at the end of this calendar year.  AFT Pharmaceuticals co-founder and managing director Dr Hartley Atkinson said the Chinese company was laying the groundwork for the product launch now. Atkinson said Shenzhen Stock Exchange-listed Hainan Haiyao had representatives meeting with doctors to raise awareness of the New Zealand produ...

More Markets

James Miller to join Fletcher Building board
Infrastructure

James Miller to join Fletcher Building board

Miller is chair of Channel Infrastructure and will need to juggle some directorships.

Ryman's model is shaking up Oz retirement sector
Property

Ryman's model is shaking up Oz retirement sector

“It's a NZ innovation that Australians can't steal," says Ryman's COO. 

NZ sharemarket ends week up nearly 1.2%
Markets Market close

NZ sharemarket ends week up nearly 1.2%

The S&P/NZX 50 Index closed at 12,904.11, up 149.96 points or 1.18%.

Graham Skellern 20 Dec 2024
Marlborough Wine Estates' NZX delisting gets green light
Markets

Marlborough Wine Estates' NZX delisting gets green light

Cost savings were behind the decision to delist, the company says.

John Anthony 20 Dec 2024